Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Lancet (London, England)"
topic_facet:"Randomized Controlled Trial"
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=topic_facet%3A%22Randomized+Controlled+Trial%22&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29&lookfor=%22antibodies%22&type=Subject
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=topic_facet%3A%22Randomized+Controlled+Trial%22&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29&lookfor=%22antibodies%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=topic_facet%3A%22Randomized+Controlled+Trial%22&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29&lookfor=%22antibodies%22&type=Subject
PubPharm (15)
1
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years : a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial
enthalten in:
Lancet (London, England)
| 2022
von
Li, G.
|
Cappuccini, F.
|
Marchevsky, N.
| +70
CommentIn: Lancet. 2022 Jun 11;399(10342):2171-2173. - PMID 35691308
Wird geladen...
2
Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716) : a randomised, double-blind, phase 3 trial
enthalten in:
Lancet (London, England)
| 2022
von
Luke, J.
|
Rutkowski, P.
|
Queirolo, P.
| +26
CommentIn: Nat Rev Clin Oncol. 2022 Jun;19(6):359. - PMID 35440772
Wird geladen...
3
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial
enthalten in:
Lancet (London, England)
| 2022
von
RECOVERY Collaborative Group
|
Abani, O.
|
Abbas, A.
| +98
CommentIn: Lancet. 2022 Feb 12;399(10325):609-610. - PMID 35151380
Wird geladen...
4
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001) : a phase 4, non-inferiority, single blind, randomised study
enthalten in:
Lancet (London, England)
| 2022
von
Costa Clemens, S.
|
Weckx, L.
|
Clemens, R.
| +44
CommentIn: Lancet. 2022 Feb 5;399(10324):496-497. - PMID 35074137
Wird geladen...
5
Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC) : a double-blind, placebo-controlled, phase 3, randomised trial
enthalten in:
Lancet (London, England)
| 2022
von
ITAC (INSIGHT 013) Study Group
|
Polizzotto, M.
|
Nordwall, J.
| +86
Wird geladen...
6
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older : an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial
enthalten in:
Lancet (London, England)
| 2022
von
Halperin, S.
|
Ye, L.
|
MacKinnon-Cameron, D.
| +46
CommentIn: Lancet. 2022 Jan 15;399(10321):212-213. - PMID 34953524
Wird geladen...
7
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV) : a single-blind, randomised, non-inferiority trial
enthalten in:
Lancet (London, England)
| 2021
von
Liu, X.
|
Shaw, R.
|
Stuart, A.
| +86
CommentIn: Lancet. 2021 Sep 4;398(10303):819-821. - PMID 34370969
Wird geladen...
8
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac) : interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey
enthalten in:
Lancet (London, England)
| 2021
von
Tanriover, M.
|
Doğanay, H.
|
Akova, M.
| +74
CommentIn: Lancet. 2020 Dec 12;396(10266):1882-1883. - PMID 33308466
Wird geladen...
9
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised controlled, open-label, platform trial
enthalten in:
Lancet (London, England)
| 2021
von
RECOVERY Collaborative Group
|
Abani, O.
|
Abbas, A.
| +98
CommentIn: Lancet. 2021 May 29;397(10289):2024-2025. - PMID 34000255
Wird geladen...
10
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial
enthalten in:
Lancet (London, England)
| 2021
von
RECOVERY Collaborative Group
|
Abani, O.
|
Abbas, A.
| +98
CommentIn: Lancet. 2021 May 1;397(10285):1599-1601. - PMID 33933194
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: Lancet (London, England)
Filter aufheben
Thema: Randomized Controlled Trial
Medienart
15
Aufsätze
15
E-Artikel
15
E-Ressourcen
Zeitschriftentitel
Lancet (London, England)
Thema
15
Journal Article
Randomized Controlled Trial
11
Antibodies, Viral
11
COVID-19 Vaccines
10
Research Support, Non-U.S. Gov't
8
Antibodies, Neutralizing
7
Clinical Trial, Phase III
6
Clinical Trial, Phase II
6
Multicenter Study
5
Immunoglobulin G
4
B5S3K2V0G8
4
ChAdOx1 nCoV-19
4
Spike Glycoprotein, Coronavirus
3
Antibodies, Monoclonal, Humanized
3
Vaccines, Inactivated
2
5AHC3V2UQS
2
Ad5-nCoV vaccine
2
Antiviral Agents
2
BNT162 Vaccine
2
Clinical Trial, Phase I
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
6
2022
7
2021
2
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
15
Englisch
Haven't found what you're looking for?
Wird geladen...